2L8H
Chemical probe bound to HIV TAR RNA
Summary for 2L8H
Entry DOI | 10.2210/pdb2l8h/pdb |
NMR Information | BMRB: 17408 |
Descriptor | HIV TAR RNA, ARGININE, 4-methoxynaphthalen-2-amine (3 entities in total) |
Functional Keywords | rna |
Biological source | synthetic construct |
Total number of polymer chains | 1 |
Total formula weight | 9655.98 |
Authors | Davidson, A.,Begley, D.,Lau, C.,Varani, G. (deposition date: 2011-01-12, release date: 2011-03-23, Last modification date: 2024-05-15) |
Primary citation | Davidson, A.,Begley, D.W.,Lau, C.,Varani, G. A Small-Molecule Probe Induces a Conformation in HIV TAR RNA Capable of Binding Drug-Like Fragments. J.Mol.Biol., 410:984-996, 2011 Cited by PubMed Abstract: The HIV-1 transactivation response (TAR) element-Tat interaction is a potentially valuable target for treating HIV infection, but efforts to develop TAR-binding antiviral drugs have not yet yielded a successful candidate for clinical development. In this work, we describe a novel approach toward screening fragments against RNA that uses a chemical probe to target the Tat-binding region of TAR. This probe fulfills two critical roles in the screen: by locking the RNA into a conformation capable of binding other fragments, it simultaneously allows the identification of proximal binding fragments by ligand-based NMR. Using this approach, we have discovered six novel TAR-binding fragments, three of which were docked relative to the probe-RNA structure using experimental NMR restraints. The consistent orientations of functional groups in our data-driven docked structures and common electrostatic properties across all fragment leads reveal a surprising level of selectivity by our fragment-sized screening hits. These models further suggest linking strategies for the development of higher-affinity lead compounds for the inhibition of the TAR-Tat interaction. PubMed: 21763501DOI: 10.1016/j.jmb.2011.03.039 PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
